PF-07328948

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NamePF-07328948
Drug Alias NamePF-07328948
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBranched-chain alpha-ketoacid dehydrogenase kinase inhibitors
TargetsBranched-chain alpha-ketoacid dehydrogenase kinase
Therapy Area/IndicationsHeart FailureRenal InsufficiencyHepatic Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[15] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer (Beijing) Research and Development Co LtdPfizer Inc
Inactive CompaniesN/A
Active IndicationsHeart FailureRenal InsufficiencyHepatic Insufficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A